Operating Metrics 營運指標
Vertex Pharmaceuticals Incorporated (VRTX) Operating Metrics 營運指標
Vertex Pharmaceuticals Incorporated VRTX 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
- TRIKAFTA / KAFTRIO Revenue
- $10,078.0M · 2026-06-30 來源：Vertex Pharmaceuticals / SEC EDGAR、Vertex Pharmaceuticals、Vertex Pharmaceuticals、Vertex Pharmaceuticals
- ALYFTREK Revenue
- $1,625.1M · 2026-06-30 來源：Vertex Pharmaceuticals / SEC EDGAR、Vertex Pharmaceuticals、Vertex Pharmaceuticals、Vertex Pharmaceuticals
- CASGEVY Revenue
- $190.5M · 2026-06-30 來源：Vertex Pharmaceuticals / SEC EDGAR、Vertex Pharmaceuticals、Vertex Pharmaceuticals、Vertex Pharmaceuticals
- JOURNAVX Revenue
- $124.9M · 2026-06-30 來源：Vertex Pharmaceuticals / SEC EDGAR、Vertex Pharmaceuticals、Vertex Pharmaceuticals、Vertex Pharmaceuticals
- JOURNAVX Prescriptions Filled
- ~535 K prescriptions · 2026-06-30 來源：Vertex Pharmaceuticals / SEC EDGAR
- JOURNAVX Covered Lives
- ~260 M people · 2026-06-30 來源：Vertex Pharmaceuticals / SEC EDGAR
- CASGEVY Patients Infused
- 30 patients · 2025-12-31 來源：Vertex Pharmaceuticals
- ALYFTREK Reimbursed Countries
- 25 countries · 2026-06-30 來源：Vertex Pharmaceuticals / SEC EDGAR
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| TRIKAFTA / KAFTRIO Revenue | $2,497.2M | $2,354.7M | $2,572.5M | $2,653.6M | $2,551.1M | $2,535.5M | $2,720.8M | $2,585.0M |
| ALYFTREK Revenue | $573.6M | $424.4M | $380.1M | $247.0M | $156.8M | $53.9M | — | — |
| CASGEVY Revenue | $76.4M | $42.9M | $54.3M | $16.9M | $30.4M | $14.2M | $8.0M | $2.0M |
| JOURNAVX Revenue | $49.6M | $29.0M | $26.7M | $19.6M | $12.0M | $1.3M | — | — |
| JOURNAVX Prescriptions Filled | ~535 K prescriptions | >350 K prescriptions | — | — | — | — | — | — |
| JOURNAVX Covered Lives | ~260 M people | ~240 M people | >200 M people | >170 M people | — | ~94 M people | — | — |
| CASGEVY Patients Infused | — | — | 30 patients | 10 patients | — | — | — | — |
| ALYFTREK Reimbursed Countries | 25 countries | — | — | — | — | — | — | — |
資料來源
- Vertex Reports Second Quarter 2026 Financial Results — Exhibit 99.1 · Vertex Pharmaceuticals / SEC EDGAR · 2026-08-03
- Vertex Reports First Quarter 2026 Financial Results · Vertex Pharmaceuticals · 2026-05-04
- Vertex Reports Fourth Quarter and Full Year 2025 Financial Results · Vertex Pharmaceuticals · 2026-02-12
- Vertex Reports Third Quarter 2025 Financial Results · Vertex Pharmaceuticals · 2025-11-03